Abstract:Summary1. Vascular adrenoceptors play an important role in vascular physiology and pathophysiology, such as hypertension, atherosclerosis and restenosis after angioplasty. To define the changes in the ene expression in vascular smooth muscle cells in response to the activation of α1‐ or β‐adrenoceptors, a DNA microarray was used.2. First, the existence of α1‐ and β‐adrenoceptors in A7r5 aortic smooth muscle cells was confirmed by radioligand binding. Then, the inhibitory effects of phenylephrine (an α1‐adrenoceptor agonist) and isoproterenol (a β‐adrenoceptor agonist) on the proliferation of A7r5 cells were determined by [3H]‐thymidine incorporation.3. The A7r5 cells were treated with 10 µmol/L phenylephrine or 1 µmol/L isoproterenol for 24 h and changes in gene expression were detected with the DNA microarray. Only 14 and 20 genes were identified after treatment of cells with phenylephrine and isoproterenol, respectively, and most genes displayed decreased expression. The changed genes could be grouped into five major functional categories: cell signalling/communication, cell structure/motility, cell/organism defence, gene/protein expression and metabolism. The gene expression profile in response to the activation of α1‐adrenoceptors was very different from that following activation of β‐adrenoceptors. Interestingly, many phenylephrine‐responsive genes were associated with metabolism, whereas many isoproterenol‐responsive genes encoded cell signalling and structure proteins. This means that adrenoceptors may modulate multiple aspects of biological function in vascular smooth muscle cells.4. Collectively, the activation of both α1‐adrenoceptors (with phenylephrine) and β‐adrenoceptors (with isoproterenol) inhibited the proliferation of A7r5 cells, but microarray data revealed that the mechanisms may be different: the activation of α1‐adrenoceptors could induce the expression of metabolic genes, resulting in the inhibition of proliferation, whereas activation of β‐adrenoceptors altered the expression of genes that encoded cell signalling and structure proteins to inhibit cell proliferation.

A Common Polymorphism in the Adenylyl Cyclase Type 9 (AC9) Gene Does Not Alter Vascular Responses to Isoproterenol

Alpha(1a)-Adrenergic Receptor Polymorphism And Vascular Response

The Effect of Common Polymorphisms of the β<sub>2</sub>-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization

Gene Expression Profiles in Response to the Activation of Adrenoceptors in A7r5 Aortic Smooth Muscle Cells

Variation in the Alpha2b-Adrenergic Receptor Gene (ADRA2B) and Its Relationship to Vascular Response in Vivo.

A Common Beta(1)-Adrenergic Receptor Polymorphism (Arg389gly) Affects Blood Pressure Response To Beta-Blockade

Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice

Desensitization of vascular response in vivo: contribution of genetic variation in the α2B-adrenergic receptor subtype:

Arg(389)Gly Beta(1)-Adrenoceptor Polymorphism Varies in Frequency among Different Ethnic Groups but Does Not Alter Response in Vivo

Alpha 1A-adrenergic receptor polymorphism and vascular response.

Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles

Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.

In-vivo Effects of Glu298Asp Endothelial Nitric Oxide Synthase Polymorphism.

The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization.

Novel human α1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function

ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure

Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adults

Effect of 1-adrenergic receptor gene polymorphism on ventricular arrhythmia and prognosis after myocardial infarction

Abstract 3: Loss of Type 9 Adenylyl Cyclase Triggers Reduced Phosphorylation of Hsp20 and Diastolic Dysfunction

The angiotensin-converting enzyme I/D polymorphism does not impact training-induced adaptations in exercise capacity in patients with stable coronary artery disease

Regulation of I Ks Potassium Current by Isoproterenol in Adult Cardiomyocytes Requires Type 9 Adenylyl Cyclase.